Results 41 to 50 of about 9,872 (176)

Microaxial Flow Pump Support as a Bridge to Transaxillary TAVI‐In‐TAVI in Cardiogenic Shock

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT A 79‐year‐old man presented with cardiogenic shock due to severe degeneration of a prior transcatheter aortic valve. Temporary mechanical circulatory support with a transvalvular microaxial flow pump was initiated, resulting in rapid stabilization.
Matteo Orlandi, Niccolò Ciardetti, Lucrezia Biagiotti, Maria Federica Crociani, Giulio Grandi, Miroslava Stolcova, Francesca Ristalli, Carlo Di Mario, Alessio Mattesini, Francesco Meucci   +9 more
wiley   +1 more source

Contemporary Management of Aortic Stenosis: Timing of Intervention and Lifetime Valve Management

European Journal of Clinical Investigation, Volume 56, Issue 8, August 2026.
As transcatheter treatment expands to younger and lower‐risk patients, aortic stenosis management is evolving from a single procedure to lifelong valve care. This review highlights the key challenges across the patient journey, from timely diagnosis and optimal intervention to durable valve performance, long‐term surveillance, and repeat intervention ...
Ottavia Cozzi, Thomas Pilgrim
wiley   +1 more source

CT-scan images preprocessing and segmentation to improve bioprosthesis leaflets morphological analysis.

, 2013
International audienceThe visualization of bioprosthesis leaflet morphology might help to better understand the underlying mechanism of dysfunction in degenerated aortic bioprosthesis.
Leguerrier, Alain, Haigron, Pascal, Wang, Qian, Esneault, Simon, Ruggieri, Vito Giovanni, Madeleine, Raphael, Verhoye, Jean-Philippe, Heautot, Jean-François   +7 more
core   +1 more source

The Beneficial Effect of Anticoagulation in Aortic Bioprosthesis is Associated with its Size

Brazilian Journal of Cardiovascular Surgery
Objective: To evaluate the clinical and echocardiographic outcomes in aortic valve replacement (AVR) patients with aortic bioprosthesis under oral anticoagulation (OA). Methods: Patients who underwent AVR with bioprosthesiswere prospectively enrolled.
Victor Dayan, Paula Farachio, Maria Jose Arocena, Amparo Fernandez, Diego Perez, Gerardo Soca   +5 more
doaj   +1 more source

Neo Left Main Channel Creation Using Double Stenting Alongside a Sapien 3 Aortic Valve Bioprosthesis for Left Main Coronary Obstruction Following Valve-in-Valve Transcatheter Aortic Valve Replacement: A Case Report With Review of Literature

Journal of Investigative Medicine High Impact Case Reports, 2018
Transcatheter aortic valve replacement in the setting of failed surgical bioprosthesis (valve-in-valve) is a valuable option for patients with bioprosthetic aortic stenosis or regurgitation who are deemed high risk for repeat open heart surgery. Although
Apurva D. Patel MD, MPH, Thomas Haldis DO, Kais Al Balbissi MD, Timir Paul MD, PhD   +3 more
doaj   +1 more source

Abdominal wall repair with acellular bovine pericardial membranes - Part I - Clinical and radiological findings [PDF]

Revista Brasileira de Cirurgia Plástica
Introduction: Reducing recurrence rates significantly, the use of biomaterials as “reinforcement meshes” in the repair of different abdominal wall defects has become an almost mandatory routine for the success of these repairs.
Luiz Fernando Frascino, Fernanda Ribeiro Funes Lorenzzato, Hamilton Luiz Funes, Jonas Dias de Campos Severi   +3 more
doaj   +1 more source

Single Centre Experience With the Balloon‐Expandable Myval Transcatheter Aortic Valve System in Patients With Bicuspid Anatomy: 1 Year Follow‐Up

Catheterization and Cardiovascular Interventions, Volume 108, Issue 1, Page 144-162, July 1, 2026.
ABSTRACT Background Transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve (BAV) anatomy remains challenging due to anatomical complexity and limited trial data. New‐generation balloon‐expandable valves, such as Myval, require further evaluation in this subgroup.
Balázs Magyari, Bálint Kittka, Ilona Goják, Gábor Kasza, Kristóf Schönfeld, László Botond Szapáry, Mihály Simon, Rudolf Kiss, Andrea Bertalan, Edit Várady, István Szokodi, Iván Horváth   +11 more
wiley   +1 more source

Simultaneous Transvenous Lead Extraction and Intra‐Operative Epicardial Extravascular Defibrillator (EV‐ICD) Implantation During Tricuspid Valve Replacement

Clinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Transvalvular device leads are undesirable following tricuspid valve replacement. Simultaneous lead extraction and intra‐operative EV‐ICD implantation can provide ongoing defibrillator therapy without crossing the prosthetic valve and may avoid the need for additional pacing hardware when atrioventricular conduction is preserved.
Joseph Canavan, Piers Wright, Gianluca Lucchese, Christopher Aldo Rinaldi   +3 more
wiley   +1 more source

Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis [PDF]

, 2017
Objective: The ATS 3f Enable® Bioprosthesis is a self-expanding valve with a tubular design that allows for decreased leaflet stress and preservation of aortic sinuses. We report the midterm results of a prospective, multicenter clinical study evaluating
Martens, Sven, Eckstein, Friedrich S., Kapelak, Boguslaw, Sievers, Hans-Hinrich, Carrel, Thierry, Schlensak, Christian, Sadowski, Jerzy, Bartus, Krzysztof   +7 more
core  

A rare case of aortic bioprosthesis thrombosis

, 2010
Chronic thrombosis of the Carpentier-Edwards SAY porcine aortic bioprosthesis is a very rare complication. We present the case of an 80-year-old male patient with dyspnoea NYHA class III 30 months after coronary artery bypass grafting and aortic valve ...
null J. De Sutter, null P. Selleslagh, null R. Hamerlijnck, De Sutter, Johan, Selleslagh, Philippe, Hamerlijnck, Ruben   +5 more
core   +1 more source